DV
Dividend Vision

EDSA — Edesa Biotech, Inc.

Edesa Biotech, Inc. (EDSA)

Total return is -99.1% over the past 16.1 years, 924.6 points behind SPY at 825.5%. Its deepest 1-year drawdown was 73.0%.

EDSA is an equity security in the healthcare sector that trades as a stock rather than a diversified fund structure. The company does not currently maintain a dividend distribution program, making it unsuitable for income-focused investors seeking regular yield. This security appeals primarily to growth-oriented investors interested in the biotech space rather than those prioritizing dividend income.

EDSA key facts

Asset type
Stock
Asset class
Equity
Inception date
06/21/2010
Last close
$5.35
Market cap
$50,767,084
Average volume
46000.0
Payment date
06/10/2019
Beta
1.078
Payout ratio
0.0
Forward P/E
0.1785
EPS
$-1.31